《Nature,2月11日,Coronavirus disease officially named COVID-19》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangzx
  • 发布时间:2020-02-12
  • 11 February 15:25 GMT — Coronavirus disease officially named COVID-19

    The World Health Organization has officially named the disease caused by the coronavirus COVID-19. This will replace various monikers and hashtags given to the emerging illness over the past few weeks. Most recently, on 8 February, China’s National Health Commission decided to temporarily call the disease novel coronavirus pneumonia, or NCP. But because viruses continue to spread from animals to people, this coronavirus won’t be novel for long.

    “COVID-19 stands for coronavirus disease in 2019,” said Soumya Swaminathan, chief scientist at the World Health Organization in Geneva, Switzerland, at a press briefing. She explained that there are many coronaviruses, and this style of naming will provide a format for referring to new coronavirus diseases in future years. “The virus itself is named by international group of virologists who will look into the taxonomy,” she said. “But it is important to have a name for this disease that everybody uses.”

    .....

  • 原文来源:https://www.nature.com/articles/d41586-020-00154-w
相关报告
  • 《Radiology,2月21日,Coronavirus Disease 2019 (COVID-19): A Perspective from China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-22
    • Coronavirus Disease 2019 (COVID-19): A Perspective from China Zi Yue Zu*, Meng Di Jiang*, Peng Peng Xu, Wen Chen, Qian Qian Ni, Guang Ming Lu, Long Jiang Zhang * Drs Zu and Jiang had equal contributions to this work. Published Online:Feb 21 2020https://doi.org/10.1148/radiol.2020200490 Abstract In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection occurred in Wuhan, Hubei Province, China and spread across China and beyond. On February 12, 2020, WHO officially named the disease caused by the novel coronavirus as Coronavirus Disease 2019 (COVID-19). Since most COVID-19 infected patients were diagnosed with pneumonia and characteristic CT imaging patterns, radiological examinations have become vital in early diagnosis and assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19, while highlighting the role of chest CT in prevention and disease control.
  • 《Nature,11月9日,COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-11-18
    • COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice Jian Zheng, Lok-Yin Roy Wong, Kun Li, Abhishek Kumar Verma, Miguel Ortiz, Christine Wohlford-Lenane, Mariah R. Leidinger, C. Michael Knudson, David K. Meyerholz, Paul B. McCray Jr & Stanley Perlman Nature (2020) Abstract The ongoing COVID-19 pandemic is associated with substantial morbidity and mortality. Although much has been learned in the first months of the pandemic, many features of COVID-19 pathogenesis remain to be determined. For example, anosmia is a common presentation and many patients with this finding show no or only minor respiratory signs1. Studies in animals experimentally infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19, provide opportunities to study aspects of the disease not easily investigated in human patients. Although COVID-19 severity ranges from asymptomatic to lethal2, most experimental infections provide insights into mild disease3. Here, using K18-hACE2 mice that we originally developed for SARS studies4, we show that infection with SARS-CoV-2 causes severe disease in the lung, and in some mice, the brain. Evidence of thrombosis and vasculitis was detected in mice with severe pneumonia. Furthermore, we show that infusion of convalescent plasma from a recovered patient with COVID-19 protected against lethal disease.